激光联合复方血栓通胶囊治疗CSC的疗效  

Compound Xueshuantong capsule joint laser treating central serous chorioretinopathy

作　　者：叶静[1] 杨雪艳[1] 曾胜[1] 

机构地区：[1]中国广东省佛山市中医院眼科,528000

出　　处：《国际眼科杂志》2013年第6期1160-1162,共3页International Eye Science

基　　金：2012年佛山市科技局科研立项(No.20120862)~~

摘　　要：目的:探讨复方血栓通胶囊联合激光治疗中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)疗效。方法:选取38例40眼CSC患者,随机分为治疗组和对照组两组,每组20眼,治疗组采用激光联合复方血栓通胶囊治疗,对照组采用激光治疗,比较两组在治疗效果和复发率方面的差异。结果:治疗组与对照组比较,治疗后1wk视力显著提高,两组间比较差异有显著性(P<0.05);治疗1mo后黄斑区水肿明显吸收,总有效率治疗组优于对照组,两组比较差异有统计学意义(P<0.05)。结论:激光联合复方血栓通胶囊治疗CSC,能够快速减轻症状,提高视力,减少复发,起到良好临床效果。AIM： To study the clinical effects of Compound Xueshuantong capsule combined with laser in treating central serous chorioretinopathy （CSC）. METHODS： Totally 38 patients （40 eyes） who suffered CSC were divided into two groups randomly. Laser combined with Compound Xueshuantong capsule for treatment group （n= 20） and laser was used in controlled group （n = 20） respectively. The curative effect and recurrent rate were compared in two groups. RESULTS： After 1 week treatment, the sight was increased significantly in treatment group （P〈0.05）. After 1 month treatment, the absorption of edema was significantly in treatment group （P〈0.05）. CONCLUSION： Compound Xueshuantong capsule combined with laser can relieve symptoms quickly and reduce recurrence, which was a good method for CSC.

关 键 词：中心性浆液性脉络膜视网膜病变 激光 复方血栓通胶囊 

分 类 号：R774.1[医药卫生—眼科]